Skip to contentK
Kewaunee Scientific Corp
K
KEQUKewaunee Scientific Corp Q1 2021 · 10-Q
Revenue$36.42M$36.42M−7.4% vs Q1 2020 Net Income-$598.00K-$598.00KN/M vs Q1 2020 EPS Diluted-$0.22-$0.22N/M vs Q1 2020 Gross Profit$5,881,000−15.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kewaunee Scientific Corp · CIK 55529 · Engraved from SEC EDGAR
Operating Cash Flow-$3,268,000N/M Free Cash Flowderived-$4,190,000N/M Margins · derivedGross margin16.1%−1.5 pt vs Q1 2020
Operating margin-0.8%−2.7 pt vs Q1 2020
Net margin-1.6%−2.8 pt vs Q1 2020
ended Jul 31, 2020 · filed Sep 11, 2020 · 42 d after period end